News

Rimini Street's Q2 2025 highlights include Oracle settlement, 1% revenue growth, strong client sales, margin improvements, and new partnerships ...
Q2 2025 Earnings Call Transcript July 30, 2025 Blackbaud, Inc. beats earnings expectations. Reported EPS is $1.21, ...
Oracle Corp. (ORCL) is gearing up for a rocky start to trading on Monday, as pre-market activity suggests a notable drop. The ...
The company introduced the world’s first autonomous database, marking a significant milestone in data management.
Oracle is tightening its AI cloud approach with a one-two punch: on-site Bloom Energy power and global-scale Digital Realty ...
Zacks Investment Research on MSN6d
Oracle (ORCL) Laps the Stock Market: Here's Why
Oracle (ORCL) closed at $247.71 in the latest trading session, marking a +1.06% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 0.02%. Elsewhere, the Dow saw ...
"To support our bull case, we believe that [Oracle] will likely raise incremental debt (we are assuming an additional $20bn of debt) to meet this bull case, which at a 5% interest rate would increase ...
Oracle is reportedly in talks for a cloud deal with Skydance-Paramount worth $100 million, signaling a strategic expansion into entertainment tech. This move could transform Oracle's market presence ...
As for this week, there were further developments on the tariff front. This in turn had an influential impact on markets.
Influence Muscle. At RFK Jr.’s HHS, It’s Not Pharma. It’s Wellness. by Stephanie Armour, KFF Health News July 18, 2025, 4:45 am Click to share on Bluesky (Opens in new window) Bluesky ...
Institutional investors are increasingly focused on private company research and investment opportunities as these firms develop technologies that influence mature sectors, the source added.